America Movil SAB de CV ADR (AMX)vsVertex Pharmaceuticals Inc (VRTX)
AMX
America Movil SAB de CV ADR
$24.76
+4.52%
COMMUNICATION SERVICES · Cap: $70.61B
VRTX
Vertex Pharmaceuticals Inc
$454.97
+1.42%
HEALTHCARE · Cap: $113.95B
Smart Verdict
WallStSmart Research — data-driven comparison
America Movil SAB de CV ADR generates 7763% more annual revenue ($943.64B vs $12.00B). VRTX leads profitability with a 32.9% profit margin vs 8.8%. AMX appears more attractively valued with a PEG of 1.17. AMX earns a higher WallStSmart Score of 69/100 (B-).
AMX
Strong Buy69
out of 100
Grade: B-
VRTX
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+67.3%
Fair Value
$72.07
Current Price
$24.76
$47.31 discount
Margin of Safety
+36.5%
Fair Value
$716.04
Current Price
$454.97
$261.07 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Generating 42.7B in free cash flow
Large-cap with strong market position
Every $100 of equity generates 21 in profit
Attractively priced relative to earnings
Strong operational efficiency at 20.1%
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 39.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 23 in profit
Conservative balance sheet, low leverage
Areas to Watch
3.4% revenue growth
4.0% earnings growth
Trading at 72.8x book value
Distress zone — elevated risk
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : AMX
The strongest argument for AMX centers on Free Cash Flow, Market Cap, Return on Equity. PEG of 1.17 suggests the stock is reasonably priced for its growth.
Bull Case : VRTX
The strongest argument for VRTX centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 32.9% and operating margin at 39.6%.
Bear Case : AMX
The primary concerns for AMX are Revenue Growth, EPS Growth, Price/Book. Debt-to-equity of 2.53 is elevated, increasing financial risk.
Bear Case : VRTX
The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
AMX profiles as a value stock while VRTX is a mature play — different risk/reward profiles.
AMX carries more volatility with a beta of 0.37 — expect wider price swings.
VRTX is growing revenue faster at 9.5% — sustainability is the question.
AMX generates stronger free cash flow (42.7B), providing more financial flexibility.
Bottom Line
AMX scores higher overall (69/100 vs 66/100). VRTX offers better value entry with a 36.5% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
America Movil SAB de CV ADR
COMMUNICATION SERVICES · TELECOM SERVICES · USA
Amrica Mvil, SAB de CV provides telecommunications services in Latin America and internationally. The company is headquartered in Mexico City, Mexico.
Visit Website →Vertex Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Compare with Other TELECOM SERVICES Stocks
Want to dig deeper into these stocks?